SURG Long Put Strategy

SURG (SurgePays, Inc.), in the Technology sector, (Software - Application industry), listed on NASDAQ.

SurgePays, Inc. operates as a financial technology and telecommunications enterprise dedicated to serving the underbanked communities across the United States. A core component of its strategy is a blockchain-powered platform that transforms local corner stores and bodegas into vital technology hubs, providing a suite of financial and prepaid products. In its telecommunications division, the company delivers voice and SMS messaging services to subsidized, direct retail prepaid, and low-income subscribers. Furthermore, it offers subsidized mobile broadband connectivity to consumers in California, Colorado, Florida, Illinois, Maryland, Mississippi, Missouri, Nevada, New Jersey, Ohio, Oklahoma, Rhode Island, Tennessee, and Texas, alongside traditional prepaid wireless options. Beyond these primary offerings, SurgePays also extends specialized services to law firms in the mass tort industry, including marketing business intelligence, plaintiff generation, and caseload management solutions. To support its diverse operations, the company maintains a bilingual operations center that provides essential internal functions such as sales assistance, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, and lead generation.

SURG (SurgePays, Inc.) trades in the Technology sector, specifically Software - Application, with a market capitalization of approximately $7.8M, a beta of 0.20 versus the broader market, a 52-week range of 0.37-3.45, average daily share volume of 373K, a public-listing history dating back to 2018, approximately 130 full-time employees. These structural characteristics shape how SURG stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.20 indicates SURG has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long put on SURG?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current SURG snapshot

As of June 30, 2026, spot at $0.39, ATM IV 17.50%, IV rank 0.00%, expected move 5.02%. The long put on SURG below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this long put structure on SURG specifically: SURG IV at 17.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a SURG long put, with a market-implied 1-standard-deviation move of approximately 5.02% (roughly $0.02 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SURG expiries trade a higher absolute premium for lower per-day decay. Position sizing on SURG should anchor to the underlying notional of $0.39 per share and to the trader's directional view on SURG stock.

SURG long put setup

The SURG long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SURG near $0.39, the first option leg uses a $0.39 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SURG chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SURG shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$0.39N/A

SURG long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

SURG long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on SURG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on SURG

Long puts on SURG hedge an existing long SURG stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying SURG exposure being hedged.

SURG thesis for this long put

The market-implied 1-standard-deviation range for SURG extends from approximately $0.37 on the downside to $0.41 on the upside. A SURG long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long SURG position with one put per 100 shares held. Current SURG IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SURG at 17.50%. As a Technology name, SURG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SURG-specific events.

SURG long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SURG positions also carry Technology sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SURG alongside the broader basket even when SURG-specific fundamentals are unchanged. Long-premium structures like a long put on SURG are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SURG chain quotes before placing a trade.

Frequently asked questions

What is a long put on SURG?
A long put on SURG is the long put strategy applied to SURG (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With SURG stock trading near $0.39, the strikes shown on this page are snapped to the nearest listed SURG chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are SURG long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the SURG long put priced from the end-of-day chain at a 30-day expiry (ATM IV 17.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a SURG long put?
The breakeven for the SURG long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SURG market-implied 1-standard-deviation expected move is approximately 5.02%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on SURG?
Long puts on SURG hedge an existing long SURG stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying SURG exposure being hedged.
How does current SURG implied volatility affect this long put?
SURG ATM IV is at 17.50% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related SURG analysis